Free press releases distribution network?

Agency / Source: Onyx Scientific Ltd

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!



Polymorph Screening Chemistry Services CRO Onyx Scientific Announces Continued Strong Growth - Onyx Scientific provides polymorph screening throughout all stages of a drug-discovery process. Solid-state services include: salt selection; physicochemical property determinations and crystallisation studies
Polymorph Screening Chemistry Services CRO Onyx Scientific Announces Continued Strong Growth

 

PRZOOM - /newswire/ - Sunderland, Tyne and Wear, United Kingdom, 2010/07/06 - Onyx Scientific provides polymorph screening throughout all stages of a drug-discovery process. Solid-state services include: salt selection; physicochemical property determinations and crystallisation studies.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Polymorph screening specialists, Onyx Scientific Ltd – chemistry outsourcing partner to the pharma and biotech industries – today announced the record-breaking growth of its solid-state chemistry services for the discovery, analysis and scale-up of polymorphs, hydrates, amorphous phases, salts and co-crystals of Active Pharmaceutical Ingredients (APIs).

In close partnership with an international client base and often working with just a few grams of precious API material, Onyx Scientific performs highly specific polymorph screening at all stages of the drug discovery process, to both pinpoint as many crystal forms as possible, for IP protection, and to select the candidate with optimal solid-state properties.

“Polymorphs are best discovered sooner rather than later and the ultimate goal is to make sure you have the best one ” explains Tony Flinn, CEO, Onyx Scientific. “Choosing an appropriate form demands systematic screening and characterization. At Onyx we utilise a 96 well plate work flow combined with 2D X-ray Powder Diffraction, high throughput Raman Spectroscopy and an automated Zinsser Crissy platform”.

Recognised as a major strength, Onyx Scientifics’ founders and elite scientific team have the pharma industry background and solid-state chemistry expertise needed to make and characterize crystal forms and to integrate the control of solid-form properties in the manufacturing process.

Typical work programs offered in the Onyx GMP facility, include:

Mini Screens – initial, early stage polymorph screening (where material and/or budget are limited)

Standard Screens – identification of as many solid-forms as possible with in a fixed time period

Macro Screens – a complete polymorphism study with stability testing and scale-up

In addition to solid-state polymorph screening, Onyx Scientifics’ breadth of services include: salt selection, GMP custom synthesis, process development and lead optimization.

MHRA certified and conforming to international GMP standards, Onyx Scientifics’ state-of-the-art facility delivers peace-of-mind with the supply of Active Pharmaceutical Ingredients for clinical trials.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Agency / Source: Onyx Scientific Ltd

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick PRZOOM - Press & Newswire Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


Polymorph Screening Chemistry Services CRO Onyx Scientific Announces Continued Strong Growth

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name PRZOOM - Press & Newswire and LINK as the source.
 
  For more information, please visit:
Is this your article? Activate ALL web links by Upgrading to Press Release PREMIUM Plan Now!
|
Contact: Sue Jones - Onyx-Scientific.com 
+44 191 516 6516 suejones[.]onyx-scientific.com
 
PRZOOM / PRTODAY - Newswire Today disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Onyx Scientific Ltd securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!




Read Latest Press Releases From Onyx Scientific Ltd / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Press Releases:

PleurX™ Catheter System Receives FDA 510(k) Clearance for Specific Non-Malignant Recurrent Pleural Effusions
First Pulmonary Embolism Patients in Hong Kong Treated with the EKOS® System
Ipsen to Acquire Oncology Assets from Merrimack Pharmaceuticals
FDA Grants Genentech’s Cancer Immunotherapy Tecentriq® (Atezolizumab) Priority Review in Additional Type of Advanced Bladder Cancer
FDA Approves Genentech’s Lucentis® (Ranibizumab Injection) for Myopic Choroidal Neovascularization
Sugar Element of Keratan Sulfate Halts the Progress of Emphysema Finds RIKEN
Exelixis and Ipsen Amend Exclusive Licensing Agreement for the Commercialization and Development of Cabozantinib to Include Canada
FDA Extends Review of Application for OCREVUS™ (Ocrelizumab)
MDxHealth Announces AceCGT Life Science Limited as the Exclusive Distributor for SelectMDx in Hong Kong and Macao China
Pulse Certified As A Level Four Multichannel Content Agency by Veeva Systems

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
 
NewswireToday Celebrates 10 Years in Business
Find business coaching, life coaching, executive coaching and corporate coaching, best selling coaching books, ...



PREMIUM Members


Visit  BizJobs.com

Visit  Intrinsic Executive Search Ltd

Visit  Al Rowaad Advocates & Legal Consultants







 
  ©2017 PRZOOM — Limelon Advertising, Co.
Home | About PRZOOM | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneur newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today